# Safety and Efficacy of FETO in CDH: A Phase III Trial

> **NCT06884423** · NA · RECRUITING · sponsor: **Holly L Hedrick, MD** · enrollment: 80 (estimated)

## Conditions studied

- Congenital Diaphragmatic Hernia
- Pulmonary Hypoplasia

## Interventions

- **DEVICE:** FETO with GoldBAL2 Balloon and BALTACCIBDPE100 Catheter

## Key facts

- **NCT ID:** NCT06884423
- **Lead sponsor:** Holly L Hedrick, MD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-07
- **Primary completion:** 2030-04
- **Final completion:** 2032-04
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06884423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06884423, "Safety and Efficacy of FETO in CDH: A Phase III Trial". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06884423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*